间充质干细胞 for Progressive Multiple Sclerosis_Sweden

To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSC) 在多发性硬化症中 (多发性硬化症) 具有进行性疾病状况.

分类: 干细胞治疗

nbscience

合同研究组织